Botulinum Toxins in Clinical Aesthetic Practice

2019 ◽  
Vol 8 (7) ◽  
pp. 314-316
Author(s):  
David Sines

This article sets out the Jount Council for Practitioners/Cosmetic Practice Standards Authority position regarding responsible prescribing of POMs used in aesthetic practice. The guidance accords with that set down by the majority of the healthcare professional regulators and by the Royal Pharmaceutical Society. With regard to delegated prescribing, prescribers are reminded that patients remain under the oversight of the prescriber, requiring that the prescriber must be familiar with the patient through an initial face to face consultation and diagnostic assessment of the patient's suitability for treatment. This applies to the routine/planned/repeat administration of medicines that are used specifically for cosmetic purposes, such as botulinum toxins, injected local anaesthetic or topical adrenaline, and the emergency use of medicines such as hyaluronidase. Prescribers are also reminded of their obligation to address the existence of competing interests and to place the needs of the patient first and be transparent about their actions.


2020 ◽  
Vol 2 (1) ◽  
pp. 36-40
Author(s):  
David Sines

This article describes the context and challenges that relate to prescribing in the non-surgical aesthetic sector and sets out the Joint Council for Cosmetic Practitioners position regarding responsible prescribing of prescription-only medicines used in aesthetic practice. The guidance lines up with that set down by the majority of the professional healthcare regulators and by the Royal Pharmaceutical Society. With regard to delegated prescribing, prescribers are reminded that patients remain under the oversight of the prescriber, requiring them to be familiar with the patient through an initial face-to-face consultation and diagnostic assessment of the patient's suitability for treatment. This applies to the routine/planned/repeat administration of medicines that are used specifically for cosmetic purposes, such as botulinum toxins, injected local anaesthetic or topical adrenaline, and the emergency use of medicines, such as hyaluronidase. Prescribers are also reminded of their obligation to address the existence of competing interests and to place the needs of the patient first, being transparent about their actions. Readers are also directed to relevant legislation and professional guidance that is applicable to the sector.


2009 ◽  
Vol 40 (9) ◽  
pp. 4
Author(s):  
ALICIA AULT
Keyword(s):  

2003 ◽  
Author(s):  
Jean Carruthrs ◽  
Alastair Carruthrs
Keyword(s):  

Author(s):  
Dominic McIver Lopes

The main argument for the network theory of aesthetic value is that it better explains the facts about aesthetic activity than aesthetic hedonism. According to the network theory, an aesthetic value figures in a fact that lends weight to the proposition that it would be an aesthetic achievement for an agent to act in the context of an aesthetic practice. Each aesthetic practice has its own aesthetic profile, in which determinate aesthetic values are distinctively realized, and each has core aesthetic norms centred on its distinctive aesthetic profile. An account is given of the valence of aesthetic values. The theory explains why aesthetic experts disperse into almost all demographic niches, why they jointly inhabit the whole aesthetic universe, why they specialize by aesthetic domain, why they specialize by type of activity, why they specialize by activity and domain interacts, and why their expertise is rooted in relatively stable psychological traits.


Sign in / Sign up

Export Citation Format

Share Document